Sound waves vs. breast cancer: new device tested
NCT ID NCT05291507
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This early study tests a device called Muse MRgFUS that uses focused ultrasound waves to heat and destroy a portion of a breast tumor without any cuts. Thirty-four women with breast cancer will have part of their tumor ablated before their standard surgery. The goal is to see if the procedure is safe, tolerable, and feasible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huntsman Cancer Institute at University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Muse MRgFUS System (a device that uses focused ultrasound to heat and destroy tissue non-invasively)
What this could lead to
If successful, this could lead to a non-invasive option to shrink breast tumors, potentially reducing the need for more extensive surgery.
What could go wrong
This is a very early feasibility study with only 34 participants, so results may not apply widely. The device only treats part of the tumor, and safety or effectiveness are not yet proven.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.